S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The only accurate crypto trading system I know … (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The "Smart Money" Is Ready for May 1st Are You? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The only accurate crypto trading system I know … (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The "Smart Money" Is Ready for May 1st Are You? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The only accurate crypto trading system I know … (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The "Smart Money" Is Ready for May 1st Are You? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The only accurate crypto trading system I know … (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The "Smart Money" Is Ready for May 1st Are You? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
ASX:MXC

Argent BioPharma (MXC) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free MXC Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.16 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
3.70%
Price Target
N/A
Stock Analysis
Stock Analysis
MXC stock logo

About Argent BioPharma Stock (ASX:MXC)

MGC Pharmaceuticals Limited provides phytomedicines worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. In addition, the company provides Irnican that is in preclinical phase for the tetrahydrocannabinol, as well as offers ArtemiC and non-pharma products. Further, it offers consulting services, including clinical research services. MGC Pharmaceuticals Limited was founded in 2014 and is based in Subiaco, Australia.

MXC Stock News Headlines

April 1, 2024 | msn.com
MGC Pharmaceuticals rebrands as Argent BioPharma in strategic transformation
February 13, 2024 | finanznachrichten.de
MGC Pharmaceuticals Ltd: MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation
April 18, 2024 | TradeSmith (Ad)
A.I. Pioneer Issues Urgent Warning to Americans
With artificial intelligence creeping into every facet of our lives, what should you be doing to "A.I.-Proof" your future? It's the question on many of our minds.
February 13, 2024 | finance.yahoo.com
MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation
February 3, 2024 | afr.com
MGC Pharmaceuticals Ltd
February 2, 2024 | proactiveinvestors.com.au
MGC Pharma delighted with position after reset
December 15, 2023 | benzinga.com
MGC Pharmaceuticals Ltd Stock (OTC:MGCLF), Analyst Ratings, Price Targets, Predictions
December 15, 2023 | benzinga.com
MGC Pharmaceuticals Stock (OTC:MGCLF) Dividends: History, Yield and Dates
April 18, 2024 | TradeSmith (Ad)
A.I. Pioneer Issues Urgent Warning to Americans
With artificial intelligence creeping into every facet of our lives, what should you be doing to "A.I.-Proof" your future? It's the question on many of our minds.
November 30, 2023 | proactiveinvestors.com
MGC Pharmaceuticals reshuffles board and appoints joint UK broker
November 15, 2023 | uk.investing.com
MGC Pharmaceuticals Ltd (MXCDA)
November 13, 2023 | proactiveinvestors.com
MGC Pharmaceuticals reveals strategic objectives for H1 2024
August 31, 2023 | au.investing.com
MGC Pharmaceuticals hails pivot to medical products, legacy sales hit
August 29, 2023 | au.investing.com
MGC Pharmaceuticals closes SPP with funds to go toward production of cannabinoid medicines
August 14, 2023 | proactiveinvestors.com
MGC Pharmaceuticals to "move forward and speak to the FDA"
August 14, 2023 | msn.com
MGC Pharma hits another milestone in path to FDA approval for anti-inflammatory CimetraA
August 1, 2023 | proactiveinvestors.com
MGC Pharmaceuticals proposes fundraising for Australian investors
August 1, 2023 | proactiveinvestors.com
MGC Pharmaceuticals receives permission to import psilocybin mushrooms into...
August 1, 2023 | proactiveinvestors.com.au
MGC Pharmaceuticals gets first psilocybin import green light import for research facility
August 1, 2023 | finance.yahoo.com
MGC Pharmaceuticals receives permission to import psilocybin mushrooms into Europe
July 31, 2023 | msn.com
MGC Pharma nabs import approval for psilocybin to Slovenian research facility
July 30, 2023 | au.investing.com
MGC Pharmaceuticals gets green light for first import of psilocybin to research facility
July 14, 2023 | marketwatch.com
MGC Pharmaceuticals Raises GBP650,000 via Heavily Discounted Placing, Subscription
July 14, 2023 | proactiveinvestors.com
MGC Pharmaceuticals raises £0.7mln for working capital
July 13, 2023 | proactiveinvestors.com
MGC Pharmaceuticals raises A$1.335 million for working capital
July 12, 2023 | au.investing.com
MGC Pharmaceuticals clarifies shape of recent AMC Pharma order
July 7, 2023 | proactiveinvestors.com.au
MGC Pharmaceuticals "pushing on" after signing fresh $1mln order
See More Headlines
Receive MXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Argent BioPharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2019
Today
4/18/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:MXC
CUSIP
N/A
CIK
N/A
Web
www.mgcpharma.com.au
Phone
61 8 6382 3390
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($3.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-17,020,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-307.40%
Return on Assets
-58.96%

Debt

Debt-to-Equity Ratio
1,436.12
Current Ratio
0.75
Quick Ratio
0.50

Sales & Book Value

Annual Sales
$1.32 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
25.00
Book Value
A$0.04 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
43,850,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.03
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Roby Reuven Zomer (Age 44)
    Co-Founder, CEO, MD & Executive Director
    Comp: $354.02k
  • Mr. Tom Cairns
    Chief Accounting Officer
  • Ms. Yifat Steuer
    Deputy CEO & COO
  • Ms. Nicole Ann Godresse
    Global Chief Sales Officer
  • Mr. Amir Polak
    Chief Pharmaceutical Development Officer
  • Ms. Sabina Suljakovic
    Head of the Quality Assurance Department
  • Dr. Nadya Lisovoder
    Chief Medical Officer
  • Ms. Sasha Friedman
    Deputy CEO
  • Yair Tal
    Chief Information Security Officer
  • Mr. Robert Clements
    Chief Commercial Officer

Key Competitors

View All Competitors

Insiders


MXC Stock Analysis - Frequently Asked Questions

How were Argent BioPharma's earnings last quarter?

Argent BioPharma Limited (ASX:MXC) released its quarterly earnings results on Thursday, February, 28th. The company reported $0.00 earnings per share (EPS) for the quarter.

What other stocks do shareholders of Argent BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Argent BioPharma investors own include Triton Minerals (TON), Rox Resources (RXL), Northern Minerals (NTU), Medlab Clinical (MDC), Laneway Resources (LNY), iSignthis (ISX), Intel (INTC), Bod Australia (BDA), Azure Minerals (AZS) and AusCann Group (AC8).

This page (ASX:MXC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
SHOCKING Crypto Leak…
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
The “Perfect Storm” for Gold
Gold Safe Exchange
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Top 5 AI Stocks to Buy for 2024
Market Moving Trends